Skip to content
Navigate to homepage - Cerba Research

Poster – Assessing Clinical Response In Multiple Myeloma (MM) Patients Treated With Monoclonal Antibodies (Mabs): Validation Of A Daratumumab IFE Reflect Assay (DIRA) To Distinguish Malignant M-Protein From Therapeutic Antibody

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our experts and discover how we can help advance your clinical trial

Contact Us